1034 related articles for article (PubMed ID: 28512854)
1. Mogroside IIIE Attenuates LPS-Induced Acute Lung Injury in Mice Partly Through Regulation of the TLR4/MAPK/NF-κB Axis via AMPK Activation.
Tao L; Cao F; Xu G; Xie H; Zhang M; Zhang C
Phytother Res; 2017 Jul; 31(7):1097-1106. PubMed ID: 28512854
[TBL] [Abstract][Full Text] [Related]
2. Mogroside IIIE, a Novel Anti-Fibrotic Compound, Reduces Pulmonary Fibrosis through Toll-Like Receptor 4 Pathways.
Tao L; Yang J; Cao F; Xie H; Zhang M; Gong Y; Zhang C
J Pharmacol Exp Ther; 2017 May; 361(2):268-279. PubMed ID: 28280123
[TBL] [Abstract][Full Text] [Related]
3. The protective effect of dexmedetomidine on LPS-induced acute lung injury through the HMGB1-mediated TLR4/NF-κB and PI3K/Akt/mTOR pathways.
Meng L; Li L; Lu S; Li K; Su Z; Wang Y; Fan X; Li X; Zhao G
Mol Immunol; 2018 Feb; 94():7-17. PubMed ID: 29241031
[TBL] [Abstract][Full Text] [Related]
4. Protective effects of polydatin on lipopolysaccharide-induced acute lung injury through TLR4-MyD88-NF-κB pathway.
Jiang Q; Yi M; Guo Q; Wang C; Wang H; Meng S; Liu C; Fu Y; Ji H; Chen T
Int Immunopharmacol; 2015 Dec; 29(2):370-376. PubMed ID: 26507165
[TBL] [Abstract][Full Text] [Related]
5. Paeonol ameliorates lipopolysaccharides-induced acute lung injury by regulating TLR4/MyD88/ NF-κB signaling pathway.
Wang F; Zhu M; Jiang N; Zhang M; Feng L; Jia X
Pharmazie; 2019 Feb; 74(2):101-106. PubMed ID: 30782259
[TBL] [Abstract][Full Text] [Related]
6. Daidzein attenuates lipopolysaccharide-induced acute lung injury via toll-like receptor 4/NF-kappaB pathway.
Feng G; Sun B; Li TZ
Int Immunopharmacol; 2015 Jun; 26(2):392-400. PubMed ID: 25887269
[TBL] [Abstract][Full Text] [Related]
7. Ulinastatin inhibits the inflammation of LPS-induced acute lung injury in mice via regulation of AMPK/NF-κB pathway.
Li W; Qiu X; Jiang H; Zhi Y; Fu J; Liu J
Int Immunopharmacol; 2015 Dec; 29(2):560-567. PubMed ID: 26481965
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-27a alleviates LPS-induced acute lung injury in mice via inhibiting inflammation and apoptosis through modulating TLR4/MyD88/NF-κB pathway.
Ju M; Liu B; He H; Gu Z; Liu Y; Su Y; Zhu D; Cang J; Luo Z
Cell Cycle; 2018; 17(16):2001-2018. PubMed ID: 30231673
[TBL] [Abstract][Full Text] [Related]
9. Phillyrin attenuates LPS-induced pulmonary inflammation via suppression of MAPK and NF-κB activation in acute lung injury mice.
Zhong WT; Wu YC; Xie XX; Zhou X; Wei MM; Soromou LW; Ci XX; Wang DC
Fitoterapia; 2013 Oct; 90():132-9. PubMed ID: 23751215
[TBL] [Abstract][Full Text] [Related]
10. Kegan Liyan oral liquid ameliorates lipopolysaccharide-induced acute lung injury through inhibition of TLR4-mediated NF-κB signaling pathway and MMP-9 expression.
Zhang X; Sun CY; Zhang YB; Guo HZ; Feng XX; Peng SZ; Yuan J; Zheng RB; Chen WP; Su ZR; Huang XD
J Ethnopharmacol; 2016 Jun; 186():91-102. PubMed ID: 27036629
[TBL] [Abstract][Full Text] [Related]
11. Plantamajoside ameliorates lipopolysaccharide-induced acute lung injury via suppressing NF-κB and MAPK activation.
Wu H; Zhao G; Jiang K; Chen X; Zhu Z; Qiu C; Li C; Deng G
Int Immunopharmacol; 2016 Jun; 35():315-322. PubMed ID: 27089391
[TBL] [Abstract][Full Text] [Related]
12. Hyaluronan ameliorates LPS-induced acute lung injury in mice via Toll-like receptor (TLR) 4-dependent signaling pathways.
Xu C; Chen G; Yang W; Xu Y; Xu Y; Huang X; Liu J; Feng Y; Xu Y; Liu B
Int Immunopharmacol; 2015 Oct; 28(2):1050-8. PubMed ID: 26321117
[TBL] [Abstract][Full Text] [Related]
13. 23-O-acetylshengmanol-3-O-α-L-arabinoside alleviates lipopolysaccharide-induced acute lung injury through inhibiting IκB/NF-κB and MAPK/AP-1 signaling pathways.
Chen C; Li L; Liu X; Zhang D; Liu Y; Li Y
J Ethnopharmacol; 2023 Jan; 300():115725. PubMed ID: 36115602
[TBL] [Abstract][Full Text] [Related]
14. Pretreatment with the compound asperuloside decreases acute lung injury via inhibiting MAPK and NF-κB signaling in a murine model.
Qiu J; Chi G; Wu Q; Ren Y; Chen C; Feng H
Int Immunopharmacol; 2016 Feb; 31():109-15. PubMed ID: 26710167
[TBL] [Abstract][Full Text] [Related]
15. Ugonin M, a Helminthostachys zeylanica Constituent, Prevents LPS-Induced Acute Lung Injury through TLR4-Mediated MAPK and NF-κB Signaling Pathways.
Wu KC; Huang SS; Kuo YH; Ho YL; Yang CS; Chang YS; Huang GJ
Molecules; 2017 Apr; 22(4):. PubMed ID: 28368327
[No Abstract] [Full Text] [Related]
16. Isotetrandrine protects against lipopolysaccharide-induced acute lung injury by suppression of mitogen-activated protein kinase and nuclear factor-kappa B.
Liang XM; Guo GF; Huang XH; Duan WL; Zeng ZL
J Surg Res; 2014 Apr; 187(2):596-604. PubMed ID: 24331940
[TBL] [Abstract][Full Text] [Related]
17. Aucubin protects against lipopolysaccharide-induced acute pulmonary injury through regulating Nrf2 and AMPK pathways.
Qiu YL; Cheng XN; Bai F; Fang LY; Hu HZ; Sun DQ
Biomed Pharmacother; 2018 Oct; 106():192-199. PubMed ID: 29958143
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA‑93 contributes to the suppression of lung inflammatory responses in LPS‑induced acute lung injury in mice via the TLR4/MyD88/NF‑κB signaling pathway.
Gao H; Xiao D; Gao L; Li X
Int J Mol Med; 2020 Aug; 46(2):561-570. PubMed ID: 32468034
[TBL] [Abstract][Full Text] [Related]
19. Nodakenin suppresses lipopolysaccharide-induced inflammatory responses in macrophage cells by inhibiting tumor necrosis factor receptor-associated factor 6 and nuclear factor-κB pathways and protects mice from lethal endotoxin shock.
Rim HK; Cho W; Sung SH; Lee KT
J Pharmacol Exp Ther; 2012 Sep; 342(3):654-64. PubMed ID: 22637723
[TBL] [Abstract][Full Text] [Related]
20. Fisetin Alleviates Lipopolysaccharide-Induced Acute Lung Injury via TLR4-Mediated NF-κB Signaling Pathway in Rats.
Feng G; Jiang ZY; Sun B; Fu J; Li TZ
Inflammation; 2016 Feb; 39(1):148-157. PubMed ID: 26272311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]